Latest Breaking News On - Ono pharmaceutical - Page 6 : comparemela.com

Ono Pharma s Plan to Become a Global Player Picks Up a New Piece With $2 4B Deciphera Acquisition

Ono Pharma s Plan to Become a Global Player Picks Up a New Piece With $2 4B Deciphera Acquisition
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesGyo sagaraEuropeans medicines agencyBristol myers squibbMono groupOno pharmaceuticalDeciphera pharmaceuticalJapan based onoBristol myersTexas based shattuck labs

Japan s ONO pays $2 4 billion for Qinlock-maker Deciphera

Japan s ONO pays $2 4 billion for Qinlock-maker Deciphera
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesGyo sagaraBristol myers squibbDeciphera pharmaceuticalsOno pharmaceuticalCymabay therapeuticsShattuck labs

Ono Pharmaceutical acquires Deciphera Pharmaceuticals for $2 4B

The $2.4 billion deal will bring Deciphera’s cancer drugs Qinlock, vimseltinib and DCC-3116 under Ono Pharmaceutical’s umbrella.

United statesGyo sagaraSteven hoerterAmbrx biopharmaMono groupEscient pharmaceuticalsDrug administrationDeciphera pharmaceuticalsOno pharmaceuticalGilead scienceCymabay therapeuticsHarpoon therapeutics

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Recommendation based on results from CheckMate -901, the first Phase 3 trial with an immunotherapy-chemotherapy combination to demonstrate a survival benefit versus standard-of-care chemotherapy.

United statesSouth koreaBristol myers squibbDana walkerEuropean medicines agencyCompany opdivoGlobal programExchange commissionEuropean unionEuropean commissionCommittee for medicinal products human useOno pharmaceutical coDrug administrationEuropean society of medical oncologyMedicinal productsHuman use

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomHaihe biopharmaBiocity biopharmaCalithera biosciencesTerremoto biosciencesBridgene biosciencesEli lillyTimothya yapRadiopharm theranosticsArtios pharmaDaiichi sankyoInstitut gustave roussyAduro biotech incAtrin pharmaceuticals